BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Friday reported a loss of $22.1 million in its third quarter.
On a per-share basis, the Berkeley, California-based company said it had a loss of 38 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 52 cents per share.
The biopharmaceutical company posted revenue of $53,000 in the period.
Dynavax Technologies shares have risen fivefold since the beginning of the year. The stock has more than doubled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX at https://www.zacks.com/ap/DVAX